GursharanSamraMD

Cardiology

Internal Medicine/ Resident

Dr. Samra is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Beth Israel Deaconess Medical CenterFellowship, Clinical Cardiac Electrophysiology, 2024 - 2026
Allegheny Health Network Medical Education Consortium (AGH)Fellowship, Cardiovascular Disease, 2021 - 2024
American University of Antigua College of MedicineClass of 2018
Cleveland Clinic FoundationResidency, Internal Medicine

PubMed

6 citations
Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway.
Rohit Moudgil, Gursharan Samra, Kyung Ae Ko, Hang Thi Vu, Tamlyn N. Thomas
Frontiers in Cardiovascular Medicine. 2020-11-06
54 citations
A Contemporary 20-Year Cleveland Clinic Experience of Nonbacterial Thrombotic Endocarditis: Etiology, Echocardiographic Imaging, Management, and Outcomes.
Mohammad Zmaili, Jafar Alzubi, Duygu Kocyigit, Agam Bansal, Gursharan Samra
The American Journal of Medicine. 2021-03-01
2 citations
Mitral Annular Calcification Related Infective Endocarditis: A Contemporary Systematic Review.
Ashwin Kumar, Gursharan Samra, Simrat Kaur, Gregory Ogunnowo, Duygu Kocyigit
Current Problems in Cardiology. 2023-03-01

Journal Articles

Topoisomerase 2B Decrease Results in Diastolic Dysfunction via p53 and Akt: A Novel Pathway
Rohit Moudgil, Gursharan Samra, Frontiers in Cardiovascular Medicine